Characterization of a novel porcine endothelin(B) receptor splice variant |
| |
Authors: | Nambi P Wu H L Ye D Gagnon A Elshourbagy N |
| |
Affiliation: | Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA, USA. |
| |
Abstract: | Screening of porcine cerebellum cDNA library with porcine endothelin(B) (ET(B)) receptor cDNA revealed a novel ET(B) receptor cDNA that is distinctly different from the wild-type ET(B) receptor in length and the amino acid sequence at the C-terminal end. This sequence appears to represent alternate splicing of the carboxy terminal end of ET(B) receptor, resulting in a polypeptide of 429 amino acids in length, which is 14 amino acids shorter than the wild-type porcine ET(B) receptor. Characterization of the wild-type and alternately spliced ET(B) receptors expressed in COS cells revealed that both receptors displayed very similar binding [apparent dissociation constant (K(d)) and maximum binding (B(max)) for (125)I-ET-1 were 71 pM and 1.6 pmol/mg protein for wild-type and 81 pM and 1.2 pmol/mg protein for splice variant ET(B) receptors] as well as functional properties. These data suggest that the differences in the amino acids at the C-terminal end had no effect on binding or functional coupling of these alternately spliced ET(B) receptors. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|